Lv31
350 积分 2021-09-01 加入
The Toxicology of Interleukin-12: A Review
1个月前
已关闭
Practical Considerations in Determining Adversity and the No-Observed-Adverse-Effect-Level (NOAEL) in Nonclinical Safety Studies: Challenges, Perspectives and Case Studies
2个月前
已完结
Toxicologic Pathology Forum*: Opinion on Qualitative Severity Descriptors to Express Magnitude of Changes in Clinical Pathology Endpoints in Nonclinical Toxicity Studies
2个月前
已完结
The evolving role of investigative toxicology in the pharmaceutical industry
4个月前
已完结
Catalytic in vivo protein knockdown by small-molecule PROTACs
4个月前
已完结
p63 is a cereblon substrate involved in thalidomide teratogenicity
4个月前
已完结
Toxicological Aspects of PROTACs
4个月前
已完结
Recent Developments in PROTAC‐Mediated Protein Degradation: From Bench to Clinic
4个月前
已完结
Safety, Pharmacokinetics, and Efficacy of TY-9591 (Deuterated Osimertinib Derivative) in Advanced EGFR-mutated Non-Small Cell Lung Cancer: A Phase 1 Dose-Escalation and Dose-Expansion Study
7个月前
已关闭
The challenges and strategies for treatment of hematological malignancies in China
1年前
已完结
皖公网安备34019202002308
